Filing Details
- Accession Number:
- 0001209191-10-050702
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-10-18 19:06:48
- Reporting Period:
- 2009-09-30
- Filing Date:
- 2010-10-18
- Accepted Time:
- 2010-10-18 19:06:48
- Original Submission Date:
- 2009-10-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1010086 | Siga Technologies Inc | SIGA | Pharmaceutical Preparations (2834) | 133864870 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 740740 | Macandrews & Forbes Llc | 35 East 62Nd Street New York NY 10065 | No | No | Yes | No | |
| 918939 | Macandrews & Forbes Holdings Inc. | 35 East 62Nd Street New York NY 10065 | Yes | No | Yes | No | |
| 1186472 | O Ronald Perelman | 35 East 62Nd Street New York NY 10065 | No | No | Yes | No | |
| 1473497 | Sth Partners, L.p. | C/O Matthew H. Kamens, Cozen O'Connor 1900 Market Street Philadelphia PA 19103 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2009-09-30 | 1,845,396 | $1.88 | 4,317,618 | No | 4 | X | Indirect | Owned through partially-owned corporation |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2009-09-30 | 444,666 | $7.80 | 3,872,952 | No | 4 | F | Indirect | Owned through partially-owned corporation |
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2009-09-30 | 3,851,969 | $6.24 | 3,851,969 | No | 4 | P | Indirect | Owned through partially-owned limited partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Indirect | Owned through partially-owned corporation |
| No | 4 | F | Indirect | Owned through partially-owned corporation |
| No | 4 | P | Indirect | Owned through partially-owned limited partnership |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Disposition | 2009-09-30 | 1,845,396 | $0.00 | 1,845,396 | $1.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-01-08 | 2011-01-08 | No | 4 | X | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | 5,962,032 | Indirect | Owned through wholly-owned corporation |
Footnotes
- Represents securities held by TransTech Pharma, Inc. ("TTP"), a corporation in which Ronald O. Perelman, a joint filer hereunder, has a direct ownership interest. Mr. Perelman disclaims beneficial ownership of the securities reported on the Form 4 as owned by TTP, except to the extent of his pecuniary interest therein. None of MacAndrews & Forbes Holdings Inc., MacAndrews & Forbes LLC or STH Partners, L.P., a limited partnership in which MacAndrews & Forbes LLC has a direct ownership interest and a joint filer hereunder ("STH"), has any pecuniary interest in securities held by TTP.
- On September 30, 2009, STH acquired 3,851,969 shares of Common Stock in a privately negotiated purchase from TTP.
Billionaire Hedge Funds
